Search

Qinghong Fu

from Plainsboro, NJ
Age ~53
Get Report
Also known as:
Quinghong Fu, Fu Qinghong
Phone and address:
79 Tennyson Dr, Plainsboro, NJ 08536
(609) 275-4640
Connected to:
Angelo Fu, 35Chen W Fu, 92Ching Fu, 62Cynthia W Fu, 48Guoguang Fu, 44Haojun Fu, 49Joan C Fu, 62Joshua S Fu, 61Kehui K Fu, 36Kiu B Fu

Qinghong Fu Phones & Addresses

  • 79 Tennyson Dr, Plainsboro, NJ 08536 (609) 275-4640
  • Edison, NJ
  • Wichita, KS
  • Rahway, NJ
  • Trenton, NJ
  • Middlesex, NJ
  • 79 Tennyson Dr, Plainsboro, NJ 08536

Publications

Us Patents

Aryl Pyridines And Methods Of Their Use

View page
US Patent:
8153804, Apr 10, 2012
Filed:
Jul 31, 2006
Appl. No.:
11/497539
Inventors:
David J. Augeri - Princeton NJ, US
Qinghong Fu - Plainsboro NJ, US
Michael Victor Voronkov - Pennington NJ, US
Doan Hackley - San Diego CA, US
Michael E. Mertzman - Belmont CA, US
Marianne Carlsen - Yardley PA, US
Assignee:
Lexicon Pharmaceuticals, Inc. - The Woodlands TX
International Classification:
C07D 213/38
C07D 417/10
C07D 401/04
C07D 401/10
C07D 213/73
A61P 35/00
US Classification:
546194, 544238, 5462707, 5462777, 5462684, 546311
Abstract:
Aryl pyridines, compositions comprising them, and methods of their use for the treatment, prevention and management of a variety of diseases and disorders are disclosed.

O-Linked Pyrimidin-4-Amine-Based Compounds, Compositions Comprising Them, And Methods Of Their Use To Treat Cancer

View page
US Patent:
20080146571, Jun 19, 2008
Filed:
Dec 12, 2007
Appl. No.:
11/954433
Inventors:
David J. Augeri - Princeton NJ, US
Marianne Carlsen - Yardley PA, US
Kenneth G. Carson - Princeton NJ, US
Qinghong Fu - Plainsboro NJ, US
Jason P. Healy - Flemington NJ, US
Theodore C. Jessop - Lawrenceville NJ, US
Philip E. Keyes - Flemington NJ, US
Min Shen - Pennington NJ, US
James E. Tarver - Morrisville PA, US
Jerry A. Taylor - Trenton NJ, US
Xiaolian Xu - Princeton NJ, US
International Classification:
A61K 31/506
C07D 239/47
C07D 403/12
A61K 31/519
A61P 35/00
A61K 31/5377
C07D 491/044
C07D 413/12
US Classification:
5142358, 544317, 544296, 544250, 544212, 544123, 514274, 514267, 514241
Abstract:
O-linked pyrimidin-4-amine-based compounds, pharmaceutical compositions comprising them, and methods of their use are described. Particular compounds of the invention are of formula I:

4-Amino-1H-Pyrimidin-2-One Based Compounds, Compositions Comprising Them And Methods Of Their Use

View page
US Patent:
20080182847, Jul 31, 2008
Filed:
Dec 12, 2007
Appl. No.:
11/954421
Inventors:
David J. Augeri - Princeton NJ, US
Marianne Carlsen - Yardley PA, US
Kenneth G. Carson - Princeton NJ, US
Qinghong Fu - Plainsboro NJ, US
Theodore C. Jessop - Lawrenceville NJ, US
James E. Tarver - Morrisville PA, US
Jerry A. Taylor - Trenton NJ, US
International Classification:
A61K 31/517
A61K 31/513
C07D 403/02
US Classification:
514249, 514269, 5142662, 544284, 544295, 544317
Abstract:
4-Amino-1H-pyrimidin-2-one-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of various diseases and disorders are disclosed. Particular compounds are of formula I:

Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use

View page
US Patent:
20110312911, Dec 22, 2011
Filed:
Feb 3, 2010
Appl. No.:
13/148577
Inventors:
Roman Kats-Kagan - Brooklyn NY, US
Christian P. Stevenson - Hoboken NJ, US
Xibin Liao - Edison NJ, US
Qinghong Fu - Plainsboro NJ, US
Emma R. Parmee - Scotch Plains NJ, US
Songnian Lin - Monroe NJ, US
International Classification:
A61K 31/197
C07C 255/59
C07D 215/20
C07D 207/327
C07D 213/64
C07D 333/24
C07D 277/64
A61K 31/47
A61K 31/40
A61K 31/4418
A61K 31/381
A61K 31/428
A61K 31/366
A61K 31/397
A61K 31/365
A61K 31/357
A61K 31/485
A61K 31/41
A61K 31/5415
A61K 31/426
A61K 31/4439
A61K 38/28
A61K 38/31
A61K 31/44
A61K 31/702
A61K 31/4985
A61K 31/403
A61K 31/506
A61K 31/454
A61P 3/10
A61P 5/50
C07C 229/38
US Classification:
514 54, 562444, 558415, 546177, 548561, 546300, 549 77, 548180, 514563, 514311, 514427, 514351, 514438, 514367, 514460, 51421002, 514423, 514449, 514454, 514282, 514381, 5142242, 514369, 514342, 514 65, 514 71, 514348, 514249, 514412, 514274, 514326
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Inhibitors Of The Renal Outer Medullary Potassium Channel

View page
US Patent:
20180009807, Jan 11, 2018
Filed:
Jan 25, 2016
Appl. No.:
15/544295
Inventors:
- Rahway NJ, US
Qinghong Fu - Plainsboro NJ, US
Jinlong Jiang - Scotch Plains NJ, US
Haifeng Tang - Metuchen NJ, US
International Classification:
C07D 471/10
C07D 487/10
C07D 451/00
A61K 31/55
A61K 31/435
A61K 31/5386
A61K 31/46
A61K 31/444
C07D 498/10
A61K 45/06
Abstract:
The present invention provides compounds of Formula I (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Inhibitors Of The Renal Outer Medullary Potassium Channel

View page
US Patent:
20170275283, Sep 28, 2017
Filed:
Oct 26, 2015
Appl. No.:
15/505277
Inventors:
Alexander PASTERNAK - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Jinlong JIANG - Kenilworth NJ, US
Haifeng TANG - Kenilworth NJ, US
Xin GU - Kenilworth NJ, US
Reynalda K. DEJESUS - Kenilworth NJ, US
Jessica FRIE - West Point PA, US
Qinghong FU - Plainsboro NJ, US
Takao SUZUKI - Shanghai, CN
Zhifa PU - Shanghai, CN
- Rahway NJ, US
International Classification:
C07D 471/10
C07D 498/10
A61K 31/5386
A61K 45/06
A61K 31/435
A61K 31/537
C07D 498/20
A61K 31/553
A61K 31/499
A61K 31/55
Abstract:
The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Inhibitors Of The Renal Outer Medullary Potassium Channel

View page
US Patent:
20170275298, Sep 28, 2017
Filed:
Oct 26, 2015
Appl. No.:
15/505254
Inventors:
- Rahway NJ, US
Shuzhi Dong - Plainsboro NJ, US
Xin Gu - Scotch Plains NJ, US
Jinlong Jiang - Scotch Plains NJ, US
Zhi-Cai Shi - Monmouth Junction NJ, US
Shawn P. Walsh - Bridgewater NJ, US
Zhicai Wu - Montvale NJ, US
Yang Yu - Clark NJ, US
Ronald Ferguson, II - Scotch Plains NJ, US
Zhiqiang Guo - Morganville NJ, US
Jessica Frie - Harleysville PA, US
Takao Suzuki - Shanghai, CN
Timothy A. Blizzard - Princeton NJ, US
Qinghong Fu - Plainsboro NJ, US
Kelsey F. Vangelder - Philadelphi PA, US
International Classification:
C07D 498/10
A61K 31/435
A61K 31/501
A61K 31/506
A61K 31/444
A61K 31/5386
A61K 31/497
A61K 31/41
A61K 31/4184
A61K 31/4178
A61K 31/4422
A61K 31/55
A61K 31/401
A61K 31/675
A61K 31/551
A61K 31/4965
A61K 31/585
C07D 471/10
Abstract:
The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Inhibitors Of The Renal Outer Medullary Potassium Channel

View page
US Patent:
20160324833, Nov 10, 2016
Filed:
Dec 19, 2014
Appl. No.:
15/101481
Inventors:
Shuzhi DONG - Kenilworth NJ, US
Alexander PASTERNAK - Kenilworth NJ, US
Xin GU - Kenilworth NJ, US
Qinghong FU - Plainsboro NJ, US
Jinlong JIANG - Kenilworth NJ, US
Haifeng TANG - Kenilworth NJ, US
Reynalda K. DEJESUS - Kenilworth NJ, US
Takao SUZUKI - Shanghai, CN
- Rahway NJ, US
International Classification:
A61K 31/435
C07D 471/10
A61K 31/444
A61K 31/506
A61K 31/438
C07D 498/10
A61K 31/537
A61K 31/497
C07D 519/00
A61K 31/437
A61K 45/06
A61K 31/501
Abstract:
Novel spirocyclic compounds of formula I: and pharmaceutically acceptable salts thereof are disclosed as inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. Pharmaceutical compositions and methods of treatment are also included.
Control profile
Qinghong Fu from Plainsboro, NJ, age ~53 Get Report